Condition
What the finding is, how it is assessed, which treatments address it in Glasgow, what will not work, how long results take and what moves the cost.
Volume loss is structural. Fat pads shrink and slide, the bone underneath resorbs at the eye socket and the jaw, and the ligaments holding the soft tissue relax. The face looks tired before it looks lined. Replacing volume where it was lost helps. Adding volume where it was not lost produces the heavy look people recognise immediately and cannot name.
Treatments that address this
The face is not a single cushion of fat that deflates evenly. It is a set of discrete compartments, separated by septa, sitting on bone and held in position by retaining ligaments. Those compartments do not age at the same rate. The deep medial cheek fat and the fat at the temple shrink early. The superficial compartments below them tend to hold their volume for longer and, as the deep support beneath them fails, they slide downward.
That is why the visible signs are so often described as descent rather than emptiness. The fold between the nose and the mouth deepens not because something has grown there but because tissue that used to sit higher is now resting on it. The jaw loses its clean line for the same reason.
Bone changes underneath at the same time. The eye socket widens with age, particularly at its lower outer rim. The angle of the jaw becomes less acute and the chin projects less. Skin, meanwhile, loses collagen and elastin, so it no longer retracts over a smaller underlying volume. Four separate processes, one appearance.
The face does not simply deflate. It empties in some places, slides in others, and loses the frame it was hung on.
An assessment that only looks at the fold you point to will treat the fold you point to. That is the most common route to a face that has been filled and still does not look rested. The finding is almost never where the complaint is.
A proper assessment works through the face in layers and in compartments. It considers the temple and the lateral cheek before the midface, because support at the top changes what the midface needs. It looks at the face in animation, not only at rest, because tissue that behaves normally when you smile is telling you something different from tissue that bunches. It records what is already in the face from previous treatment, where it was placed and when, because old filler alters both the anatomy and the plan.
The output of that assessment is a written plan naming the areas, the order and the reasoning. What the consultation covers sets out the full sequence.
Volume that has been lost can be replaced. The treatments that do this reliably are injectable and they work at depth, on bone or in the deep fat, rather than close to the surface where a superficial bolus creates a visible ridge.
In practice the sequence matters more than the product. Structure is restored before contour, the upper face before the lower, and a first treatment is deliberately conservative so that there is room to add at review.
A great deal of money is spent in this field on treatments aimed at the wrong finding. Volume loss is the clearest example because it is so often confused with two other problems that look identical in a bathroom mirror.
The first is laxity. If the skin and soft tissue have genuinely relaxed and there is excess, filling underneath it makes the excess heavier. It does not lift. The face becomes wider and flatter, and the result reads as puffiness rather than youth. Surgery is the answer that matches significant laxity, and a clinic that will not say so is selling.
The second is shadow. A hollow under the eye may be a genuine loss of volume, or it may be a skeletal ridge casting a shadow, or pigmentation, or a fluid pattern that changes hour to hour. Filler placed into the wrong one of those produces a puffy, blue-tinged under eye that can persist for years.
Ask whether the product being proposed can be dissolved, and whether the practitioner holds hyaluronidase on the premises and is competent to use it in an emergency. Hyaluronic acid fillers can be reversed. Several other categories cannot. That single difference should change what you agree to.
Topical products cannot restore fat or bone, and no device currently marketed to the public reverses bone resorption. Improving skin quality is worth doing and it changes how light falls on the face, but it is not a substitute for structure.
Filler placed at depth is visible immediately, but the immediate appearance includes swelling and is not the result. Judging on the day is the most reliable way to talk yourself into more product than you need. Swelling settles over the first fortnight and the tissue integrates over the same period.
Longevity depends on the gel, the plane and the area. Firm gels on bone in a relatively static area such as the chin or the lateral cheek outlast soft gels in mobile tissue. Manufacturers commonly quote periods of a year or more for structural products, and less for softer ones. Individual metabolism, exercise load and the amount placed all move that number, so a range is more truthful than a figure.
What matters more than the calendar is what happens when it fades. A well planned face returns to its own baseline gradually. A face that has been overfilled repeatedly does not, because tissue has been stretched. That is the argument for treating less at a time and reviewing.
No figure is published on this site, and the reason is not evasion. Cost for this condition is driven almost entirely by how many compartments need addressing and how much product that takes, and neither can be known before the face has been assessed. A quotation given before an assessment is a guess dressed up as a price.
The variables that actually move the number are worth knowing before you compare two quotations:
A quotation that is materially cheaper than others usually differs on one of those five points. What drives the price of treatment explains each of them in full.
Restoring facial volume involves placing material near the vascular supply of the face. The complication that matters, vascular occlusion, is rare, and it is managed by preparation rather than by luck. That makes the practitioner question more important here than for almost any other treatment.
Regulation in Scotland is narrower than most people assume. Independent clinics where the service is provided by a doctor, dentist, nurse, midwife or dental care professional must register with Healthcare Improvement Scotland and are inspected. Practitioners outside those groups fall outside that requirement altogether, and dermal fillers are regulated as medical devices rather than medicines, so there is currently no general licence required to inject them at all.
The standards to expect from any clinic in Glasgow covers the full list of checks.
Common questions
Lift the tissue gently upward and outward in front of a mirror. If the appearance improves markedly with a small lift and there is visible excess when you release it, laxity is a significant part of the picture and filler alone will disappoint. If the face looks flat and shadowed rather than loose, volume is the more likely finding. That distinction should be made at assessment, not by you, but knowing it exists changes the conversation.
It should not, and when it does it is a planning failure rather than an inevitable consequence. Volume placed where volume was lost restores proportion. Volume placed where nothing was lost, or in quantities beyond what the face has capacity for, widens it. The safeguard is treating conservatively at a first appointment and judging at review.
It can be, and it often should not be. Staging allows each step to be judged once swelling has settled and prevents the compounding of small errors across several areas. Where several compartments need attention, sequencing over a few months usually produces a better and cheaper outcome than doing everything at once.
Not directly. Botulinum toxin type A reduces muscle contraction and replaces nothing. It has a supporting role where a muscle is actively pulling tissue downward, and it addresses movement lines that often accompany volume loss, but it is not a treatment for the volume itself.
Collagen-stimulating injectables and energy devices increase collagen in the treated tissue, which improves skin quality and can add a modest amount of thickness. That is a genuine effect and it is not the same as restoring a lost fat compartment. Expect refinement rather than replacement, and expect it to take months rather than weeks.
Related reading
01
A medical device rather than a medicine in the UK, which is precisely why the practitioner matters more than the product.
Read
02
Not one procedure but a marketing umbrella over several. Knowing which is which is the whole decision.
Read
03
Two reasons. Advertising a prescription-only medicine such as botulinum toxin to the public is prohibited under UK med...
Read
Enquiries
Tell us what you have noticed and how long it has been there. You will get a considered reply setting out which treatments apply to that finding, which do not, and what an assessment would need to establish first.
hello@aestheticlaunchlab.comPlease do not send clinical photographs or medical records by email. If something has gone wrong after a procedure, contact the practitioner who treated you, or NHS 111 in Scotland, rather than waiting for a reply.